PARIS & CODOLET, France--(BUSINESS WIRE)--The funds managed by Argos Soditic announce the acquisition, together with the management, of Cisbio Bioassays. This cutting-edge biotechnology company is the leader in the field of products and services for human in vitro diagnostics and pharmaceutical research. Through this Management Buy-Out (MBO) operation Cisbio Bioassays becomes independent, with its spin-off departure from the Belgian group IBA.
Help employers find you! Check out all the jobs and post your resume.
